PARK7 and neuroblastoma: In vitro, Zerumbone can increase levels of PARK7, Nrf2 and HO-1, improve the viability of human neuroblastoma cells treated with 1-methyl-4-phenylpyridinium and reduce the ROS content and the number of apoptosis (Cao et al., 2018).